Focus topics

China’s first mRNA vaccine receives approval – in Indonesia

China’s first mRNA COVID-19 vaccine received emergency approval in Indonesia. The vaccine, called AWcorna, received approval for people aged 18 years and above and may be used as an initial vaccine and as a booster vaccine. The vaccine is developed by Walvax Biotechnology, Suzhou Abogen Biosciences and the Chinese military, Bloomberg reports.

Continue reading now

Get 30 days of free access to the Professional Briefing to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Germany approves Sinovac vaccine
    TSMC triples investment in Arizona
    EU advances WTO case against China
    Xi travels to Saudi Arabia